telbermin
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2003 (NCT00069446)
Timeline
Indications
Studied for
Mechanism of action
Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR) agonist
- Vascular endothelial growth factor AINHIBITOR
VEGFA inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108557 ↗
Also known as
- rh-vegf
- telbermin
- telbermin
- telbermin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00351767 | Phase 2 | Jan 1, 2006 | Genentech |
| NCT00069446 | Phase 1 | Aug 1, 2003 | Genentech |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genentech | For profit | 2 | 2 | 2 | 2003 |
1 organizations
Page 1 / 1